{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:17:17Z","timestamp":1792696637323,"version":"4.5.0"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5716","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T22:08:20Z","timestamp":1462054100000},"page":"1043-1048","source":"Crossref","is-referenced-by-count":30,"title":["The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome"],"prefix":"10.2169","volume":"55","author":[{"given":"Erdem","family":"Koçak","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Çanakkale State Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Akbal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Çanakkale Onsekizmart University Hospital Çanakkale, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyfettin","family":"Köklü","sequence":"additional","affiliation":[{"name":"Department of Hacettepe, University Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Ergül","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ankara Education and Research Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Can","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Bulent Ecevit University, Faculty of Medicine, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 123: 2108-2131, 2002.","DOI":"10.1053\/gast.2002.37095"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 45: 98-101, 2011.","DOI":"10.1097\/MCG.0b013e31821fbf44"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kopp E, Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 15: 396-401, 2003.","DOI":"10.1016\/S0952-7915(03)00080-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Harris G, Kuolee R, Chen W. Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J Gastroenterol 14: 2149-2160, 2006.","DOI":"10.3748\/wjg.v12.i14.2149"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ljubisavljevic S, Stojanovic I, Pavlovic D, et al. Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms. Acta Neurobiol Exp 72: 33-39, 2012.","DOI":"10.55782\/ane-2012-1878"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Toda N, Herman AG. Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol Rev 57: 315-338, 2005.","DOI":"10.1124\/pr.57.3.4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36: 1440-1443, 1990.","DOI":"10.1093\/clinchem\/36.8.1440"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep 10: 385-390, 2008.","DOI":"10.1007\/s11894-008-0073-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ohman L, Lindmark AC, Isaksson S, et al. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil 21: 644-650, 2009.","DOI":"10.1111\/j.1365-2982.2009.01272.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 104: 1205-1212, 2009.","DOI":"10.1038\/ajg.2009.116"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dinan TG, Quigley EM, Ahmed SM, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130: 304-311, 2006.","DOI":"10.1053\/j.gastro.2005.11.033"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133: 24-33, 2007.","DOI":"10.1053\/j.gastro.2007.04.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Aerssens J, Camilleri M, Talloen W, et al. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 6: 194-205, 2008.","DOI":"10.1016\/j.cgh.2007.11.012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122: 1778-1783, 2002.","DOI":"10.1053\/gast.2002.33579"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Macsharry J, O'Mahony L, Fanning A, et al. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Scand J Gastroenterol 43: 1467-1476, 2008.","DOI":"10.1080\/00365520802276127"},{"key":"17","unstructured":"17. Wang XM, Liu YL. Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome. Zhonghua Yi Xue Za Zhi 88: 3415-3417, 2008 (in Chinese, Abstract in English)."},{"key":"18","unstructured":"18. Wang XM, Liu YL. An investigation of signal transduction pathway of colonic mucosal toll-like receptor 4 in patients with diarrhea-irritable bowel syndrome. Zhonghua Nei Ke Za Zhi 49: 491-494, 2010 (in Chinese, Abstract in English)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Brint EK, MacSharry J, Fanning A, Shanahan F, Quigley EM. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 106: 329-336, 2011.","DOI":"10.1038\/ajg.2010.438"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McKernan DP, Gaszner G, Quigley EM, Cryan JF, Dinan TG. Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther 33: 1045-1052, 2011.","DOI":"10.1111\/j.1365-2036.2011.04624.x"},{"key":"21","unstructured":"21. Belmonte L, Beutheu Youmba S, Bertiaux-Vandaële N, et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS One 7: 1371, 2012."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Szebeni B, Veres G, Dezsõfi A, et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 151: 34-41, 2008.","DOI":"10.1111\/j.1365-2249.2007.03531.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017, 2000.","DOI":"10.1128\/IAI.68.12.7010-7017.2000"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 42: 414-420, 1998.","DOI":"10.1136\/gut.42.3.414"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sykes MA, Blanchard EB, Lackner J, et al. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med 26: 361-372, 2003.","DOI":"10.1023\/A:1024209111909"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhang Y, Zhang Y, Miao J, et al. Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J Neuroimmunol 204: 13-19, 2008.","DOI":"10.1016\/j.jneuroim.2008.08.011"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ozdil K, Sahin A, Calhan T, et al. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterol 31: 96-102, 2011.","DOI":"10.1186\/1471-230X-11-96"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Barbara G, Cremon C, Pallotti F. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 48: 95-97, 2009.","DOI":"10.1097\/MPG.0b013e3181a15e2e"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Miller MJ, Sandoval M. Nitric Oxide. III. A molecular prelude to intestinal inflammation. Am J Physiol 276: 795-799, 1999.","DOI":"10.1152\/ajpgi.1999.276.4.G795"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Toda N, Herman AG. Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol Rev 57: 315-338, 2005.","DOI":"10.1124\/pr.57.3.4"},{"key":"31","unstructured":"31. Boyle FC, Craig JW, Muir TC. Nitric oxide in inhibitory transmission in the guinea-pig lower oesophageal sphincter. Br J Pharmacol 104: 5, 1991."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tomita R, Fujisaki S, Ikeda T, Fukuzawa M. Role of nitric oxide in the colon of patients with slow-transit constipation. Dis Colon Rectum 45: 593-600, 2002.","DOI":"10.1007\/s10350-004-6251-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kuiken SD, Klooker TK, Tytgat GN, Lei A, Boeckxstaens GE. Possible role of nitric oxide in visceral hypersensitivity. Neurogastroenterol Motil 18: 115-122, 2006.","DOI":"10.1111\/j.1365-2982.2005.00731.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/9\/55_55.5716\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T04:16:58Z","timestamp":1718511418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/9\/55_55.5716\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5716","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}